Madison Avenue Partners LP Purchases New Position in Molina Healthcare, Inc $MOH

Madison Avenue Partners LP purchased a new stake in Molina Healthcare, Inc (NYSE:MOH) in the fourth quarter, HoldingsChannel reports. The fund purchased 633,877 shares of the company’s stock, valued at approximately $110,003,000. Molina Healthcare comprises about 4.7% of Madison Avenue Partners LP’s investment portfolio, making the stock its 9th biggest position.

A number of other institutional investors have also recently made changes to their positions in the business. Man Group plc lifted its holdings in shares of Molina Healthcare by 9.1% in the 4th quarter. Man Group plc now owns 61,331 shares of the company’s stock valued at $10,643,000 after acquiring an additional 5,114 shares during the last quarter. Inspire Investing LLC lifted its holdings in shares of Molina Healthcare by 6.4% in the 4th quarter. Inspire Investing LLC now owns 6,535 shares of the company’s stock valued at $1,134,000 after acquiring an additional 391 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in shares of Molina Healthcare by 369.2% in the 4th quarter. Janus Henderson Group PLC now owns 25,926 shares of the company’s stock valued at $4,501,000 after acquiring an additional 20,400 shares during the last quarter. Gotham Asset Management LLC raised its position in Molina Healthcare by 28.8% in the 4th quarter. Gotham Asset Management LLC now owns 92,568 shares of the company’s stock worth $16,064,000 after purchasing an additional 20,673 shares during the period. Finally, Eversept Partners LP raised its position in Molina Healthcare by 380.1% in the 4th quarter. Eversept Partners LP now owns 45,470 shares of the company’s stock worth $7,891,000 after purchasing an additional 36,000 shares during the period. Institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.44% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Robert W. Baird increased their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Truist Financial increased their price objective on shares of Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a research report on Monday, May 11th. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research report on Tuesday, April 21st. JPMorgan Chase & Co. increased their price objective on shares of Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a research report on Monday, June 8th. Finally, Mizuho set a $215.00 price objective on shares of Molina Healthcare in a research report on Monday, June 8th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $182.73.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $195.39 on Thursday. The firm has a market capitalization of $10.18 billion, a P/E ratio of 57.81 and a beta of 0.80. The company’s 50-day moving average is $178.29 and its 200 day moving average is $165.71. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $311.52. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The company’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period last year, the company posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.